Title Cost-benefit, cost-effectiveness research of drug abuse prevention : implications for programming and policy / editors, William J. Bukoski, Richard I. Evans.

Publication Info.

Item Status

Location	Call No.	Status	OPAC Message	Public Note	Gift Note
Moore Stacks	HV5825 .C67 1998 1998	Available	---

Description	iv, 233 pages : illustrations ; 24 cm.
Series	NIDA research monograph ; 176
	NIH publication ; no. 98-4021
	NIDA research monograph ; 176.
	NIH publication ; no. 98-4021.
Note	"Based on the papers from a technical review ... held on July 28-29, 1994."--p. ii.
Bibliography	Includes bibliographical references.
Contents	Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary.
Subject	Drug abuse -- United States -- Prevention -- Finance.
	Drug abuse.
	United States.
	Finance.
Added Author	Bukoski, William J.
	Evans, Richard I. (Richard Isadore), 1922-2015.
	National Institute on Drug Abuse. Division of Epidemiology and Prevention Research.
	National Institutes of Health (U.S.)